Pierre Catignol and Huisub Lim of Samsung Biologics discuss how the company is applying the Power of One to mRNA, investing in a one-stop solution to facilitate the advance of customer mRNA molecules from the clinic to commercialization, including product and process development and characterization.
.svg)
